Treatment of Tuberculosis. Morbidity and Mortality Weekly Report Recommendations and Reports June 20 2003; 52(RR-11)1-77
This report presents recommendations for the treatment of tuberculosis.
This report presents recommendations for the treatment of tuberculosis.
This manual is a handbook for use by state and local health departments to improve their TB control programs that require collaboration with healthcare providers in the community.
This report provides preliminary information about 21 cases of liver injury associated with rifampin-pyrazinamide (RIF-PZA) and the revised recommendations on selecting appropriate therapy for patients with latent TB infection and monitoring the use of RIF-PZA to treat infection.
This guideline presents updated data about drug interactions between protease inhibitors and non-nucleoside reverse transcriptase inhibitors for treatment of HIV infection together with rifamycins for treatment of TB.
This notice explains that on September 30, 1999, the Food and Drug Administration approved a reformulated amplified Mycobacterium Tuberculosis Direct (MTD) test for detection of Mycobacterium tuberculosis in acid-fast Bacille (AFB) smear-positive and smear-negative respiratory specimens from...